拓尔思 reported revenue of ¥0.13B for the period ended 2026-06-30, -48.4% year on year. Net income was ¥-0.17B, a -135.1% net margin on a 61.4% gross margin. The largest revenue line is 人工智能软件产品及服务 at 45% of the total. Free cash flow for the period was ¥-0.05B.
| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.13B | -48.4% |
| Gross profit | ¥0.08B | — |
| Operating income | ¥-0.17B | — |
| Net income | ¥-0.17B | — |
| Gross margin | 61.4% | Net margin -135.1% |
| Revenue Q/Q | -6.8% | — |
| Segment | Revenue | Share |
|---|---|---|
| 人工智能软件产品及服务 | ¥0.06B | 44.6% |
| 大数据软件产品及服务 | ¥0.04B | 31.4% |
| 安全产品 | ¥0.02B | 12.5% |
| 系统集成及其他 | ¥0.01B | 11.6% |
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.05B | 38.6% |
| R&D | ¥0.06B | 46.0% |
| SG&A | ¥0.18B | 146.2% |
| Tax & other | ¥-0.00B | -2.4% |
| Item | Amount |
|---|---|
| Total assets | ¥3.98B |
| Total liabilities | ¥0.30B |
| Shareholders' equity | ¥3.68B |
| Equity / assets | 92.5% |
| Operating cash flow | ¥-0.03B |
| Capital expenditure | ¥0.02B |
| Free cash flow | ¥-0.05B |
| Cash conversion (OCF / net income) | 51% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
永利股份 ・ 银信科技 ・ 洲明科技 ・ 金城医药 ・ 开尔新材 ・ 方直科技 ・ 上海新阳 ・ ST美晨 ・ 冠昊生物 ・ 东宝生物 ・ 飞力达 ・ 瑞丰光电
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies